What is Footbeat?
Footbeat operates as a medical device company focused on enhancing lower extremity circulation. Its core product, FOOTBEAT, is a micro-mobile engine designed to be worn discreetly within a shoe or sock. This insole technology provides cyclic thrusting pressure to the foot's capillary bed at the plantar venous plexus, aiding in augmenting circulation. The applications for FOOTBEAT span a range of prescriptive and elective medical therapies, including support for athletic recovery and for individuals experiencing extended periods of sitting or immobility.
How much funding has Footbeat raised?
Footbeat has raised a total of $7.6M across 1 funding round:
Series A
$7.6M
Series A (2016): $7.6M, investors not publicly disclosed
What's next for Footbeat?
The recent major strategic investment in Footbeat signals a pivotal growth phase for the company. This capital infusion is likely earmarked for scaling production, expanding market reach, and further research and development into new therapeutic applications. Given the enterprise-level funding context, Footbeat is poised to solidify its position in the medical device market, potentially exploring partnerships to integrate its technology into broader healthcare solutions or athletic performance platforms. The company's focus on circulation augmentation addresses a significant need in both medical and wellness sectors.
See full Footbeat company page
